Literature DB >> 6360884

Neurogenic actions of angiotensin II.

C M Ferrario.   

Abstract

It has become increasingly evident that blood-borne angiotensin II has major effects upon brain cardiovascular centers. With the discovery of an angiotensin I-forming enzyme or isoenzymes in the central nervous system of mammals, alternative concepts have emerged regarding the role of this peptide in the regulation of central adrenoreceptor activity, pituitary function, and hydromineral metabolism. These concepts are reviewed, and a framework for future research is suggested by the author.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6360884     DOI: 10.1161/01.hyp.5.6_pt_3.v73

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

Review 1.  Renal sympathetic nerve activity in the development of hypertension.

Authors:  Simon C Malpas; Rohit Ramchandra; Sarah-Jane Guild; Fiona McBryde; Carolyn J Barrett
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

Review 2.  Importance of the renin-angiotensin-aldosterone system (RAS) in the physiology and pathology of hypertension. An overview.

Authors:  C M Ferrario
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Does enhanced respiratory-sympathetic coupling contribute to peripheral neural mechanisms of angiotensin II-salt hypertension?

Authors:  Glenn M Toney; Gustavo R Pedrino; Gregory D Fink; John W Osborn
Journal:  Exp Physiol       Date:  2010-03-12       Impact factor: 2.969

Review 4.  Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation.

Authors:  John W Osborn; Gregory D Fink; Marcos T Kuroki
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

5.  Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats.

Authors:  Norihito Moniwa; Jasmina Varagic; Sarfaraz Ahmad; Jessica L VonCannon; Carlos M Ferrario
Journal:  Ther Adv Cardiovasc Dis       Date:  2012-01-05

Review 6.  Pathologic consequences of increased angiotensin II activity.

Authors:  C M Ferrario; J M Flack
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

7.  DuP 753, a nonpeptide angiotensin II-1 receptor antagonist, alters dopaminergic function in rat striatum.

Authors:  L P Dwoskin; A L Jewell; L A Cassis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

Review 8.  Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension.

Authors:  V C Biancardi; J E Stern
Journal:  J Physiol       Date:  2015-12-21       Impact factor: 5.182

9.  Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats.

Authors:  Misa Yoshimoto; Kenju Miki; Gregory D Fink; Andrew King; John W Osborn
Journal:  Hypertension       Date:  2010-01-25       Impact factor: 10.190

Review 10.  Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension.

Authors:  John W Osborn; Gregory D Fink; Alan F Sved; Glenn M Toney; Mohan K Raizada
Journal:  Curr Hypertens Rep       Date:  2007-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.